Pfizer’s antiviral drug for kids begins clinical trial

Pfizer is conducting a new trial to test Paxlovid in 140 children ranging in age from 6-17. Paxlovid is currently authorized for high-risk people ages 12 and older.

March 9, 2022

Top Stories

ABC News Live Presents